Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryuta Uraki

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Uirusu|December 1, 2024
[Analysis of RNA virus pathogenicity and development of novel prevention methods.]Ryuta Uraki
Nature Chemical Biology|November 10, 2021
Host glycolipids in SARS-CoV-2 entryRyuta Uraki, Yoshihiro Kawaoka
The New England Journal of Medicine|February 1, 2023
Antiviral Agents against Omicron Subvariant BA.4.6 In Vitro. ReplyRyuta Uraki, Masaki Imai, Yoshihiro Kawaoka
Viruses|May 14, 2020
TRiC/CCT Complex, a Binding Partner of NS1 Protein, Supports the Replication of Zika Virus in Both Mammalians and MosquitoesYuchen Wang, Ryuta Uraki, Jesse Hwang, et al.
Nature Communications|June 20, 2025
Efficacy of baloxavir marboxil against bovine H5N1 virus in miceMaki Kiso, Ryuta Uraki, Seiya Yamayoshi, et al.
Nature Reviews. Microbiology|November 10, 2025
SARS-CoV-2 variants: biology, pathogenicity, immunity and controlRyuta Uraki, Bette Korber, Michael S Diamond, et al.
Iscience|September 16, 2024
Drug susceptibility and the potential for drug-resistant SARS-CoV-2 emergence in immunocompromised animalsMaki Kiso, Ryuta Uraki, Seiya Yamayoshi, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 7, 2018
Differences in the ease with which mutant viruses escape from human monoclonal antibodies against the HA stem of influenza A virusSeiya Yamayoshi, Atsuhiro Yasuhara, Mutsumi Ito, et al.
Antiviral Research|May 3, 2026
Niclosamide Inhibits the Replication of Highly Pathogenic Avian Influenza A (H5Nx) Viruses and Antiviral-Resistant MutantsShiho Chiba, Maki Kiso, Seiya Yamayoshi, et al.
International Journal of Molecular Medicine|September 7, 2010
Enhancement of phagocytotic activity by prion protein in PrP-deficient macrophage cellsRyuta Uraki, Akikazu Sakudo, Saeko Ando, et al.
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Uirusu|December 1, 2024
[Analysis of RNA virus pathogenicity and development of novel prevention methods.]Ryuta Uraki
Nature Chemical Biology|November 10, 2021
Host glycolipids in SARS-CoV-2 entryRyuta Uraki, Yoshihiro Kawaoka
The New England Journal of Medicine|February 1, 2023
Antiviral Agents against Omicron Subvariant BA.4.6 In Vitro. ReplyRyuta Uraki, Masaki Imai, Yoshihiro Kawaoka
Viruses|May 14, 2020
TRiC/CCT Complex, a Binding Partner of NS1 Protein, Supports the Replication of Zika Virus in Both Mammalians and MosquitoesYuchen Wang, Ryuta Uraki, Jesse Hwang, et al.
Nature Communications|June 20, 2025
Efficacy of baloxavir marboxil against bovine H5N1 virus in miceMaki Kiso, Ryuta Uraki, Seiya Yamayoshi, et al.
Nature Reviews. Microbiology|November 10, 2025
SARS-CoV-2 variants: biology, pathogenicity, immunity and controlRyuta Uraki, Bette Korber, Michael S Diamond, et al.
Iscience|September 16, 2024
Drug susceptibility and the potential for drug-resistant SARS-CoV-2 emergence in immunocompromised animalsMaki Kiso, Ryuta Uraki, Seiya Yamayoshi, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 7, 2018
Differences in the ease with which mutant viruses escape from human monoclonal antibodies against the HA stem of influenza A virusSeiya Yamayoshi, Atsuhiro Yasuhara, Mutsumi Ito, et al.
Antiviral Research|May 3, 2026
Niclosamide Inhibits the Replication of Highly Pathogenic Avian Influenza A (H5Nx) Viruses and Antiviral-Resistant MutantsShiho Chiba, Maki Kiso, Seiya Yamayoshi, et al.
International Journal of Molecular Medicine|September 7, 2010
Enhancement of phagocytotic activity by prion protein in PrP-deficient macrophage cellsRyuta Uraki, Akikazu Sakudo, Saeko Ando, et al.
Pageof 8